- $287.48m
- $261.22m
- $228.39m
- 61
- 61
- 26
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.78 | ||
| Price to Tang. Book | 1.98 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.26 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -17.59% | ||
| Return on Equity | -29.57% | ||
| Operating Margin | -49.2% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 78.7 | 222.61 | 237.28 | 233.25 | 228.38 | 203.29 | 222.19 | 46.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cryoport, Inc. provides supply chain solutions for the Life Sciences with a focus on cell and gene therapies. The Company enables manufacturers, contract manufacturers, contract research organizations, developers, and researchers to carry out their respective business with products and services. It provides a range of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories.
Directors
- Jerrell Shelton CHM (75)
- Robert Stefanovich CFO (56)
- Mark Sawicki SVP
- Richard Berman LED (78)
- Linda Baddour IND (62)
- Daniel Hancock IND (70)
- Robert Hariri IND (62)
- Ram Jagannath IND (44)
- Ramkumar Mandalam IND (56)
- Edward Zecchini IND (60)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 25th, 1990
- Public Since
- July 24th, 2015
- No. of Shareholders
- 153
- No. of Employees
- 1,090
- Sector
- Freight & Logistics Services
- Industry
- Industrials
- Exchange
NASDAQ Capital Market- Shares in Issue
- 49,910,391
- Address
- 112 Westwood Place, Suite 350, BRENTWOOD, 37027
- Web
- https://www.cryoport.com/
- Phone
- +1 9492321900
- Contact
- Scott Eckstein
- Auditors
- Ernst & Young LLP
Upcoming Events for CYRX
Q1 2025 Cryoport Inc Earnings Call
Cryoport Inc Annual Shareholders Meeting
Cryoport Inc Annual Shareholders Meeting
Q2 2025 Cryoport Inc Earnings Release
Similar to CYRX
Addentax
NASDAQ Capital Market
Air T
NASDAQ Capital Market
Callan JMB
NASDAQ Capital Market
Castor Maritime
NASDAQ Capital Market
Cheetah Net Supply Chain Service
NASDAQ Capital Market
FAQ
What is the CryoPort share price?
As of Today at 20:07 UTC, shares in CryoPort are trading at $5.76. This share price information is delayed by 15 minutes.
How has the CryoPort share price performed this year?
Shares in CryoPort last closed at $5.76 and the price had moved by -64.07% over the past 365 days. In terms of relative price strength the CryoPort share price has underperformed the S&P500 Index by -66.83% over the past year.
What are the analyst and broker recommendations for CryoPort?
The overall consensus recommendation for CryoPort is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the CryoPort dividend yield?
CryoPort does not currently pay a dividend.
Does CryoPort pay a dividend?
CryoPort does not currently pay a dividend.
When does CryoPort next pay dividends?
CryoPort does not currently pay a dividend.
How do I buy CryoPort shares?
To buy shares in CryoPort you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CryoPort?
As of the previous close price of $5.76, shares in CryoPort had a market capitalisation of $287.48m.
Where are CryoPort shares listed?
Here are the trading details for CryoPort:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: CYRX
What kind of share is CryoPort?
Based on an overall assessment of its quality, value and momentum CryoPort is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CryoPort share price forecast for 2025?
The analyst consensus target price for shares in CryoPort is $11.28. That is 95.83% above the last closing price of $5.76.
Analysts covering CryoPort currently have a consensus Earnings Per Share (EPS) forecast of -$1.17 for the next financial year.
Find out moreWhat is the trend in the CryoPort share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CryoPort. Over the past six months, its share price has underperformed the S&P500 Index by -11.89%.
As of the last closing price of $5.76, shares in CryoPort were trading -22.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CryoPort PE Ratio?
The CryoPort PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CryoPort?
CryoPort's management team is headed by:
- Jerrell Shelton - CHM
- Robert Stefanovich - CFO
- Mark Sawicki - SVP
- Richard Berman - LED
- Linda Baddour - IND
- Daniel Hancock - IND
- Robert Hariri - IND
- Ram Jagannath - IND
- Ramkumar Mandalam - IND
- Edward Zecchini - IND